WisdomTree extends poison pill to March 2025, raises exercise price to $45

WisdomTree, Inc.

Rights plan extended to March 17, 2025, subject to stockholder ratification at 2024 annual meeting.
Exercise price increased from $32 to $45 per right per share of common stock.
Board cites ongoing activism concerns from stockholder ETFS Capital as rationale.
Trigger thresholds remain at 10% (active) and 20% (passive) ownership to avoid dilution.
Qualifying offer clause allows stockholders to call special meeting to exempt a bid.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.